Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials
Martin B. Leon(Columbia University Irving Medical Center), Patrick W. Serruys(Erasmus MC), A. Pieter Kappetein(Erasmus University Rotterdam), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), D. Craig Miller(Harvard University), Nicolò Piazza(McGill University Health Centre), John G. Webb(St. Paul's Hospital), Stephan Windecker(University of Bern), Donald E. Cutlip(Baim Institute for Clinical Research), Pascal Vranckx(Jessa Hospital), Alec Vahanian(Université Paris Cité), Johanna J.M. Takkenberg(Erasmus University Rotterdam), Jeffrey J. Popma(Cardiovascular Research Foundation), John L. Petersen(Columbia University Irving Medical Center), Gerrit‐Anne van Es(Centre Hospitalier Universitaire de Caen Normandie), Marie‐Angèle Morel(Unknown), Mitchell W. Krucoff(Duke University), Eugene H. Blackstone(Cleveland Clinic), Eugenia Nikolsky(Columbia University Irving Medical Center), Roxana Mehran(Mount Sinai Hospital)
Cited by 734
Related Papers
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
|European Heart Journal|2015|8.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.7k
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
|New England Journal of Medicine|1994|4.5k